Premium
Changes in cognitive functioning after COVID‐19: A systematic review and meta‐analysis
Author(s) -
Crivelli Lucia,
Palmer Katie,
Calandri Ismael,
Guekht Alla,
Beghi Ettore,
Carroll William,
Frontera Jennifer,
GarcíaAzorín David,
Westenberg Erica,
Winkler Andrea Sylvia,
Mangialasche Francesca,
Allegri Ricardo F.,
Kivipelto Miia
Publication year - 2022
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1002/alz.12644
Subject(s) - meta analysis , montreal cognitive assessment , covid-19 , confidence interval , medicine , subgroup analysis , cognition , medline , systematic review , web of science , strictly standardized mean difference , cognitive impairment , disease , psychiatry , infectious disease (medical specialty) , political science , law
We conducted a systematic review and meta‐analysis of the cognitive effects of coronavirus disease 2019 (COVID‐19) in adults with no prior history of cognitive impairment. Methods Searches in Medline/Web of Science/Embase from January 1, 2020, to December 13, 2021, were performed following Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) guidelines. A meta‐analysis of the Montreal Cognitive Assessment (MoCA) total score comparing recovered COVID‐19 and healthy controls was performed. Results Oof 6202 articles, 27 studies with 2049 individuals were included (mean age = 56.05 years, evaluation time ranged from the acute phase to 7 months post‐infection). Impairment in executive functions, attention, and memory were found in post‐COVID‐19 patients. The meta‐analysis was performed with a subgroup of 290 individuals and showed a difference in MoCA score between post‐COVID‐19 patients versus controls (mean difference = −0.94, 95% confidence interval [CI] −1.59, −0.29; P = .0049). Discussion Patients recovered from COVID‐19 have lower general cognition compared to healthy controls up to 7 months post‐infection.